Literature DB >> 4110655

Brain catecholamines and breast cancer: a hypothesis.

B A Stoll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4110655     DOI： 10.1016/s0140-6736(72)90875-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Letter: Levodopa in breast cancer.

Authors:  K K Mahajan
Journal:  Br Med J       Date:  1975-08-23

2.  Letter: Breast cancer regression under oestrogen therapy.

Authors:  P Garcia Webb; M H Briggs
Journal:  Br Med J       Date:  1973-11-17

3.  Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.

Authors:  E Engelsman; J C Heuson; J Blonk Van Der Wijst; A Drochmans; H Maass; F Cheix; L G Sobrinho; H Nowakowski
Journal:  Br Med J       Date:  1975-06-28

4.  LevoDopa test and estrogen receptor assay in prognosticating responses of patients with advanced cancer of the breast to endocrine therapy.

Authors:  G H Sasaki; B S Leung; W S Fletcher
Journal:  Ann Surg       Date:  1976-04       Impact factor: 12.969

5.  Hypothesis: breast cancer regression under oestrogen therapy.

Authors:  B A Stoll
Journal:  Br Med J       Date:  1973-08-25

Review 6.  Relation of the neuroendocrine system to the development and growth of experimental mammary tumors.

Authors:  J Meites
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.